As we continue to focus on the US market with our direct sales efforts we are pleased that our Australian partner INBIO has agreed to take on majority ownership of the KK, including financial and operational responsibilities. The experience of INBIO executives in the Japanese markets as well as their proximity will enable more efficient management of our now jointly owned Japanese subsidiary. |
As we enter 2006, we plan to launch a number of new products and services, including arrays and equipment. These products and services will address established markets as well as emerging markets including molecular diagnostics and defense applications. |
Our technology continues to gain credibility with our military, as indicated by this new relationship with the U.S. Air Force. This agreement is in addition to our previously announced program with the Air Force Institute of Operational Health. Going forward we hope to expand and strengthen our relationship with the U.S. Department of Defense, Homeland Security, and other segments of our military. |
With the abundance of stellar scientists and research and clinical activities in and around the MaRS Discovery District and the fact that our Chief Scientific Officer and Vice President, Dr. Mansoor Mohammed, is a Canadian citizen, it was an easy and obvious choice for our expansion into the Canadian arena. Moving forward we anticipate establishing strong relationships with Canadian customers, partners and the government. |